Alpha 2.0
Login Register
» Authors » Giampaolo Montesi

Giampaolo Montesi

Explore the profile of Giampaolo Montesi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 156
Followers 0
Related Specialties
Oncology
Radiology
Top 10 Co-Authors
Marco Lupattelli
Maria Antonietta Gambacorta
Cynthia Aristei
Vittorio Bini
Isabella Palumbo
Antonio Pontoriero
Pierfrancesco Franco
Giuditta Chiloiro
Rita Marina Niespolo
Valentina Lancellotta
Published In
Clin Transl Radiat Oncol
Radiol Med
Anticancer Res
Clin Nucl Med
Tumori
Affiliations
Soon will be listed here.
Recent Articles
1.
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est)
Matrone F, Urso L, Girometti R, Polesel J, Sepulcri M, Pierantoni F, et al.
Ther Adv Urol . 2025 Mar; 17:17562872251321971. PMID: 40083770
Background: Next-generation imaging (NGI) technologies such as multiparametric magnetic resonance imaging (mpMRI) and total-body NGI (tbNGI) methodologies including choline, fluciclovine or PSMA positron emission tomography/computed tomography (PET/CT), whole-body MRI (wbMRI),...
2.
Stereotactic body radiotherapy combined with immunotherapy or targeted therapy: a screenshot from Italy on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO)
Corrao G, Marvaso G, Zaffaroni M, Vincini M, Badellino S, Borghetti P, et al.
Radiol Med . 2025 Mar; PMID: 40072805
Aim: Despite the widespread use of immunotherapy (IO) and targeted therapy (TT) in clinical practice, data on toxicity in combination with SBRT are lacking, largely based on retrospective studies and...
3.
RT for the management of locally advanced rectal cancer: Don't throw the baby with the bath water!
Nicosia L, Bonu M, Angelicone I, Lunardi G, Niespolo R, Zannetti M, et al.
Radiother Oncol . 2025 Feb; 205:110772. PMID: 39904412
No abstract available.
4.
Stereotactic body radiotherapy for spinal oligometastases: a survey on patterns of practice on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO)
Cuccia F, Franzese C, Badellino S, Borghetti P, Federico M, Marvaso G, et al.
Clin Exp Metastasis . 2024 Aug; 41(5):679-685. PMID: 39088084
Background: The Study Group for the Biology and Treatment of the OligoMetastatic Disease on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) has conducted a national survey...
5.
Preoperative Intensified Chemoradiation with Intensity-Modulated Radiotherapy and Simultaneous Integrated Boost Combined with Capecitabine in Locally Advanced Rectal Cancer: Long-Term Outcomes of a Real-Life Multicenter Study
Lupattelli M, Palazzari E, Polesel J, Chiloiro G, Angelicone I, Panni V, et al.
Cancers (Basel) . 2023 Dec; 15(23). PMID: 38067405
Background: Despite the feasibility and promising activity data on intensity-modulated RT and simultaneous integrated boost (IMRT-SIB) dose escalation in preoperative chemoradiation (CRT) for locally advanced rectal cancer (LARC), few data...
6.
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort
Borghetti P, Facheris G, Ciammella P, Galaverni M, Granello L, Scotti V, et al.
Clin Lung Cancer . 2023 Dec; 25(2):151-158. PMID: 38052684
Aims: SCLC is the most aggressive lung cancer histology with a 5-year OS <10%. At the diagnosis, almost two-thirds of the SCLC an Extended Disease presentation. Two randomized studies (CASPIAN...
7.
A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group
Marvaso G, Mastroleo F, Corrao G, Zaffaroni M, Vincini M, Borghetti P, et al.
Cancers (Basel) . 2023 Aug; 15(15). PMID: 37568718
The term "oligometastasis" represents a relatively novel idea, which denotes a condition characterized by cancer dissemination with a limited number of lesions (usually fewer than five). The aim of the...
8.
Pattern of care for re-irradiation in locally recurrent rectal cancer: a national survey on behalf of the AIRO gastrointestinal tumors study group
Mantello G, Galofaro E, Caravatta L, Di Carlo C, Montrone S, Arpa D, et al.
Radiol Med . 2023 Jun; 128(7):869-876. PMID: 37365381
Purpose: Radical resection (R0) represents the best curative treatment for local recurrence (LR) rectal cancer. Re-irradiation (re-RT) can increase the rate of R0 resection. Currently, there is a lack of...
9.
Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) - A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Study Group
Chiloiro G, Romano A, Mariani S, Macchia G, Giannarelli D, Caravatta L, et al.
Clin Transl Radiat Oncol . 2023 Mar; 39:100579. PMID: 36935859
Background: Patients (pts) affected with locally advanced rectal cancer (LARC) may respond differently to neoadjuvant chemoradiotherapy (nCRT). The identification of reliable biomarkers able to predict oncological outcomes could help in...
10.
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study
Nicosia L, Franceschini D, Perrone-Congedi F, Molinari A, Gerardi M, Rigo M, et al.
Clin Transl Radiat Oncol . 2023 Mar; 39:100568. PMID: 36935855
Aim: Stereotactic ablative radiotherapy (SABR) showed increasing survival in oligometastatic patients. Few studies actually depicted oligometastatic disease (OMD) evolution and which patient will remain disease-free and which will rapidly develop...